Depressive Disorder in Patients with Degenerative Connective Tissue Diseases

Fahad Javed Awan; Muhammad Zahid Hussain  Rana; Amna  Butt; Syed Fahad Ul  Hassan; Farhan  Zaid; Muhammad Obaid  Ullah

doi:10.51253/pafmj.v76i6.8798

Authors

Fahad Javed Awan Department of Medicine, Pak Emirates Military Hospital/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
Muhammad Zahid Hussain Rana Department of Medicine, Pak Emirates Military Hospital/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
Amna Butt Department of Medicine, Pak Emirates Military Hospital/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
Syed Fahad Ul Hassan Department of Medicine, Pak Emirates Military Hospital/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
Farhan Zaid Department of Medicine, Pak Emirates Military Hospital/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
Muhammad Obaid Ullah Department of Medicine, Pak Emirates Military Hospital/National University of Medical Sciences (NUMS), Rawalpindi Pakistan

DOI:

https://doi.org/10.51253/pafmj.v76i6.8798

Keywords:

Beck Depression Inventory, Connective Tissue Disorders, Depression, Pain

Abstract

Objective: To look for presence of depression in patients managed with various connective tissue disease at medicine/ rheumatology department of our hospital.

Study Design: Comparative cross-sectional study.

Place and Duration of Study: Department of Medicine and Rheumatology, Pak Emirates Military Hospital, Rawalpindi Pakistan, from Aug 2021 to May 2022.

Methodology: All the patients who were diagnosed with any degenerative connective tissue disorder by consultant medical specialist or rheumatologist were included in the study. Depressive symptoms were assessed by using the Beck Depression inventory. Factors like age, gender, presence of chronic pain and duration of illness were associated with presence of significant depression among the study participants.

Results: Out of 425 patients who were managed for connective tissue diseases in our hospital during the study period, 102(24.0%) were male while 323(76.0%) were female. Mean age of the study participants was 34.95±7.626 years. 283(66.5%) did not have significant depressive symptoms while 182(33.5%) had significant depressive symptoms. Longer duration of connective tissue disease and presence of significant chronic pain had statistically significant relationship with presence of depressive symptoms in our study participants (p-value<0.001).

Conclusion: Significant depressive symptoms were observed in considerable number of patients suffering from connective tissue diseases. Patients with longer duration of illness and those with significant chronic pain were more at risk of having depressive symptoms as compared to others.

Downloads

Download data is not yet available.

References

1. Nochaiwong S, Ruengorn C, Thavorn K, Hutton B, Awiphan R, Phosuya C, et al. Global prevalence of mental health issues among the general population during the coronavirus disease-2019 pandemic: a systematic review and meta-analysis. Sci Rep 2021; 11(1): 10173. http://doi.org/10.1038/s41598-021-89700-8

2. Charlson F, van Ommeren M, Flaxman A, Cornett J, Whiteford H, Saxena S. New WHO prevalence estimates of mental disorders in conflict settings: a systematic review and meta-analysis. Lancet 2019; 394(10194): 240-248.

http://doi.org/10.1016/S0140-6736(19)30934-1

3. Schneider F, Erhart M, Hewer W, Loeffler LA, Jacobi F. Mortality and Medical Comorbidity in the Severely Mentally Ill. Dtsch Arztebl Int 2019; 116(23-24): 405-411.

http://doi.org/10.3238/arztebl.2019.0405

4. Hiroharu K. “Effect of non-surgical interventions on pain relief and symptom improvement in farmers with diseases of the musculoskeletal system or connective tissue: an exploratory systematic review based on randomized controlled trials.” J Rural Med 2022; 17(1): 1-13.

http://doi.org/10.2185/jrm.2021-038

5. Xu N, Zhao S, Xue H, Fu WY, Liu L, Zhang TQ, et al. Associations of perceived social support and positive psychological resources with fatigue symptom in patients with rheumatoid arthritis. PLoS One 2017; 12(3): e0173293.

http://doi.org/10.1371/journal.pone.0173293

6. Liu L, Xu X, Xu N, Wang L. Disease activity, resilience and health-related quality of life in Chinese patients with rheumatoid arthritis: a multi-center, cross-sectional study. Health Qual Life Outcomes 2017; 15(1): 149.

http://doi.org/10.1186/s12955-017-0725-6

7. Wiśniewski M, Zabłocka-Żytka L. Sexual and mental health of woman suffering from selected connective tissue diseases: an original paper. Clin Rheumatol 2021; 40(8): 3319-3327.

http://doi.org/10.1007/s10067-021-05611-z

8. Jiang Y, Lin D, Zhang P, Zhang X, Lio Z, Pan Y et al. AB0823 Patients with connective tissue disease have more anxiety in comparison with patients with other rheumatic diseases. Ann Rheumat Dis 2018; 77(2): 1541.

9. Khan A, Pooja V, Chaudhury S, Bhatt V, Saldanha D. Assessment of Depression, Anxiety, Stress, and quality of life in rheumatoid arthritis patients and comparison with healthy individuals. Ind Psychiatry J 2021; 30(Suppl 1): S195-S200.

http://doi.org/10.4103/0972-6748.328861

10. Kiani IG, Qureshi SH, Shah F. Depression and seizures as the main neuropsychiatric manifestation of mixed connective tissue disorder. J Coll Physicians Surg Pak 2014; 24(Suppl 2): S141-S143.

11. Knight A, Weiss P, Morales K, Gerdes M, Gutstein A, Vickery M, et al. Depression and anxiety and their association with healthcare utilization in pediatric lupus and mixed connective tissue disease patients: a cross-sectional study. Pediatr Rheumatol Online J 2014; 12(3): 42.

http://doi.org/10.1186/1546-0096-12-42

12. John KJ, Sadiq M, George T, Gunasekaran K, Francis N, Rajadurai E, et al. Clinical and Immunological Profile of Mixed Connective Tissue Disease and a Comparison of Four Diagnostic Criteria. Int J Rheumatol 2020; 2020(1): 9692030.

http://doi.org/10.1155/2020/9692030

13. Zubair UB, Mansoor S, Rana MH. Prevalence of depressive symptoms and associated socio-demographic factors among recruits during military training. J R Army Med Corps. 2015; 161(2): 127-131.

http://doi.org/10.1136/jramc-2014-000253

14. Boonstra AM, Schiphorst Preuper HR, Balk GA, Stewart RE. Cut-off points for mild, moderate, and severe pain on the visual analogue scale for pain in patients with chronic musculoskeletal pain. Pain 2014; 155(12): 2545-2550.

http://doi.org/10.1016/j.pain.2014.09.014

15. Narupan N, Seeherunwong A, Pumpuang W. Prevalence and biopsychosocial factors associated with depressive symptoms among patients living with systemic lupus erythematosus in clinical settings in urban Thailand. BMC Psych 2022; 22(1): 103.

http://doi.org/10.1186/s12888-022-03739-z

16. Kennedy M, Loomba K, Ghani H, Riley B. The psychological burden associated with Ehlers-Danlos syndromes: a systematic review. J Osteopath Med 2022; 10.1515/jom-2021-0267.

http://doi.org/10.1515/jom-2021

17. Zabłocka-Żytka L, Wiśniewski M. Mental health of patients suffering from connective tissue diseases. Negative and positive concept and selected correlates. Psychiatr Pol 2021; 55(2): 377-396. http://doi.org/10.12740/PP/116673

18. Grygiel-Górniak B, Limphaibool N, Puszczewicz M. Cytokine secretion and the risk of depression development in patients with connective tissue diseases. Psychiatry Clin Neurosci 2019; 73(6): 302-316.

http://doi.org/10.1111/pcn.12826